| scholarly article | Q13442814 |
| P2093 | author name string | Gang Han | |
| Kun Liu | |||
| Yidong Wang | |||
| Shaowen Guo | |||
| Hangjun Gong | |||
| P2860 | cites work | The antidiabetic drug metformin inhibits gastric cancer cell proliferation in vitro and in vivo | Q39416862 |
| Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers | Q39424350 | ||
| Antisense inhibition of survivin expression as a cancer therapeutic | Q39610362 | ||
| The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level. | Q40021818 | ||
| Implication of AMP-activated protein kinase and Akt-regulated survivin in lung cancer chemopreventive activities of deguelin | Q40033668 | ||
| Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis. | Q40143359 | ||
| Metformin prevents high-glucose-induced endothelial cell death through a mitochondrial permeability transition-dependent process | Q40404137 | ||
| Ultraviolet light activates NFkappaB through translational inhibition of IkappaBalpha synthesis | Q40548006 | ||
| Survivin enhances Fas ligand expression via up-regulation of specificity protein 1-mediated gene transcription in colon cancer cells | Q40581555 | ||
| Effects of metformin on proliferation of human colon carcinoma cell line SW-480 | Q42919093 | ||
| Metformin inhibits aromatase expression in human breast adipose stromal cells via stimulation of AMP-activated protein kinase | Q43124196 | ||
| Food intake and dosage level, but not tablet vs solution dosage form, affect the absorption of metformin HCl in man. | Q46065775 | ||
| The antidiabetic drug metformin: a pharmaceutical AMPK activator to overcome breast cancer resistance to HER2 inhibitors while decreasing risk of cardiomyopathy | Q46157399 | ||
| Survivin enhances telomerase activity via up-regulation of specificity protein 1- and c-Myc-mediated human telomerase reverse transcriptase gene transcription | Q46427332 | ||
| 5-Aminoimidazole-4-Carboxamide-1- -D-Ribofuranoside and Metformin Inhibit Hepatic Glucose Phosphorylation by an AMP-Activated Protein Kinase-Independent Effect on Glucokinase Translocation | Q57800666 | ||
| Diabetes and Cancer: A Consensus Report | Q62267706 | ||
| Hallmarks of Cancer: The Next Generation | Q22252312 | ||
| Cellular and molecular mechanisms of metformin: an overview | Q27013561 | ||
| C75, a fatty acid synthase inhibitor, reduces food intake via hypothalamic AMP-activated protein kinase | Q28251163 | ||
| Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities | Q29617768 | ||
| Metformin influences cardiomyocyte cell death by pathways that are dependent and independent of caspase-3. | Q33251776 | ||
| Standards of medical care in diabetes--2010. | Q33554238 | ||
| Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis. | Q33718914 | ||
| The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism | Q34525699 | ||
| National outcomes after gastric resection for neoplasm | Q34620161 | ||
| Recent advances in multimodal treatment for gastric cancer: a review | Q36112130 | ||
| Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling | Q37620713 | ||
| Metformin: taking away the candy for cancer? | Q37775372 | ||
| Metformin is associated with improved survival in endometrial cancer | Q38165601 | ||
| Survivin beyond physiology: orchestration of multistep carcinogenesis and therapeutic potentials | Q38190309 | ||
| Targeting apoptosis for anticancer therapy | Q38214561 | ||
| Differential effects of AMPK agonists on cell growth and metabolism | Q38954598 | ||
| P433 | issue | 1 | |
| P921 | main subject | metformin | Q19484 |
| apoptotic process | Q14599311 | ||
| P304 | page(s) | 77-87 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Cancer Biology and Therapy | Q2544651 |
| P1476 | title | AMPK/mTOR-mediated inhibition of survivin partly contributes to metformin-induced apoptosis in human gastric cancer cell | |
| P478 | volume | 16 |
| Q47126247 | Attenuation of CD4+CD25+ Regulatory T Cells in the Tumor Microenvironment by Metformin, a Type 2 Diabetes Drug |
| Q42061952 | Celastrol induces cell cycle arrest by MicroRNA-21-mTOR-mediated inhibition p27 protein degradation in gastric cancer |
| Q35919503 | Correlation between survivin genetic polymorphisms and lung cancer susceptibility |
| Q37437550 | Enhanced anti-tumor activity and cytotoxic effect on cancer stem cell population of metformin-butyrate compared with metformin HCl in breast cancer |
| Q54977122 | Gastrin inhibits gastric cancer progression through activating the ERK-P65-miR23a/27a/24 axis. |
| Q38931011 | Genetic and epigenetic cancer chemoprevention on molecular targets during multistage carcinogenesis |
| Q49283314 | HDAC2 and HDAC5 Up-Regulations Modulate Survivin and miR-125a-5p Expressions and Promote Hormone Therapy Resistance in Estrogen Receptor Positive Breast Cancer Cells. |
| Q41050067 | Inhibition of N-methyl-N-nitrosourea-induced gastric tumorigenesis by Liuwei Dihuang Pill in db/db mice |
| Q61449086 | LINK-A lncRNA Promotes Proliferation and Inhibits Apoptosis of Mantle Cell Lymphoma Cell by Upregulating Survivin |
| Q37733068 | Mechanism of progestin resistance in endometrial precancer/cancer through Nrf2-survivin pathway |
| Q38740526 | Metformin Elicits Antitumor Effects and Downregulates the Histone Methyltransferase Multiple Myeloma SET Domain (MMSET) in Prostate Cancer Cells |
| Q36099266 | Metformin Increases Sensitivity of Pancreatic Cancer Cells to Gemcitabine by Reducing CD133+ Cell Populations and Suppressing ERK/P70S6K Signaling |
| Q39933909 | Metformin Inhibits TGF-β1-Induced Epithelial-to-Mesenchymal Transition via PKM2 Relative-mTOR/p70s6k Signaling Pathway in Cervical Carcinoma Cells |
| Q37697040 | Metformin enhances the radiosensitivity of human liver cancer cells to γ-rays and carbon ion beams |
| Q60911522 | Metformin induces apoptotic cytotoxicity depending on AMPK/PKA/GSK-3β-mediated c-FLIP degradation in non-small cell lung cancer |
| Q36346026 | Metformin inhibited esophageal squamous cell carcinoma proliferation in vitro and in vivo and enhanced the anti-cancer effect of cisplatin |
| Q52331264 | Metformin inhibits ovarian cancer via decreasing H3K27 trimethylation. |
| Q38854319 | Metformin inhibits the proliferation, metastasis, and cancer stem-like sphere formation in osteosarcoma MG63 cells in vitro |
| Q37274957 | Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus |
| Q36729549 | Metformin suppresses hypoxia-induced stabilization of HIF-1α through reprogramming of oxygen metabolism in hepatocellular carcinoma |
| Q37609790 | Metformin targets multiple signaling pathways in cancer |
| Q64254388 | Metformin triggers the intrinsic apoptotic response in human AGS gastric adenocarcinoma cells by activating AMPK and suppressing mTOR/AKT signaling |
| Q49183232 | Metformin use and its effect on gastric cancer in patients with type 2 diabetes: A systematic review of observational studies |
| Q37733377 | New insight for metformin against bladder cancer |
| Q55125583 | Non-thermal plasma treatment improves chicken sperm motility via the regulation of demethylation levels. |
| Q61800285 | PCK1 negatively regulates cell cycle progression and hepatoma cell proliferation via the AMPK/p27 axis |
| Q57072227 | Phenformin and metformin inhibit growth and migration of LN229 glioma cells in vitro and in vivo |
| Q64089678 | Rab1A promotes proliferation and migration abilities via regulation of the HER2/AKT-independent mTOR/S6K1 pathway in colorectal cancer |
| Q38695734 | Repurposing metformin for the prevention of cancer and cancer recurrence |
| Q41472442 | Sestrin 2 suppresses cells proliferation through AMPK/mTORC1 pathway activation in colorectal cancer |
| Q64120581 | Therapeutic cancer prevention: achievements and ongoing challenges - a focus on breast and colorectal cancer |
| Q92015313 | Two novel 1,4‑naphthoquinone derivatives induce human gastric cancer cell apoptosis and cell cycle arrest by regulating reactive oxygen species‑mediated MAPK/Akt/STAT3 signaling pathways |
Search more.